atipamezole has been researched along with morphine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kalso, EA; Kontinen, VK | 1 |
Dickenson, AH; Stanfa, LC | 1 |
Kauppila, T; Taira, T; Tanila, H | 1 |
Muir, WW; Ueyama, Y; Ueyema, Y; Waselau, AC; Wiese, AJ | 1 |
Cahill, CM; Jhamandas, K; Milne, B; Sutak, M | 1 |
Kalso, EA; Kambur, O; Lilius, TO; Rauhala, PV; Rossi, SM; Väänänen, AJ | 1 |
Cahill, CM; Grenier, P; Jhamandas, K; Milne, B; Sutak, M | 1 |
Cahill, CM; Grenier, P; Olmstead, MC; Wiercigroch, D | 1 |
8 other study(ies) available for atipamezole and morphine
Article | Year |
---|---|
Is there any cross-antagonism between mu-opioid and alpha 2-adrenergic receptors in the rat spinal cord?
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Analgesics, Opioid; Animals; Drug Interactions; Imidazoles; Male; Medetomidine; Morphine; Naloxone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Spinal Cord | 1995 |
Enhanced alpha-2 adrenergic controls and spinal morphine potency in inflammation.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Carrageenan; Dioxanes; Dose-Response Relationship, Drug; Drug Synergism; Evoked Potentials; Idazoxan; Imidazoles; Inflammation; Injections, Spinal; Male; Medetomidine; Morphine; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2 | 1994 |
Inhibition of intestinal motility and reversal of postlaparotomy ileus by selective alpha 2-adrenergic drugs in the rat.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Gastric Emptying; Gastrointestinal Motility; Imidazoles; Intestinal Obstruction; Laparotomy; Male; Medetomidine; Morphine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha | 1993 |
Anesthetic and cardiopulmonary effects of intramuscular morphine, medetomidine, ketamine injection in dogs.
Topics: Adrenergic alpha-Antagonists; Analgesia; Anesthesia; Anesthetics; Animals; Dogs; Drug Therapy, Combination; Female; Imidazoles; Ketamine; Male; Medetomidine; Morphine; Time Factors | 2008 |
Low doses of alpha 2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Idazoxan; Imidazoles; Male; Mianserin; Mirtazapine; Morphine; Rats; Rats, Sprague-Dawley; Spine; Yohimbine | 2008 |
Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Tolerance; Hot Temperature; Imidazoles; Injections, Spinal; Injections, Subcutaneous; Male; Morphine; Pain; Pain Measurement; Pain Threshold; Pressure; Rats; Rats, Sprague-Dawley; Time Factors | 2012 |
Analgesia, enhancement of spinal morphine antinociception, and inhibition of tolerance by ultra-low dose of the α2A-adrenoceptor selective antagonist BRL44408.
Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesia; Analgesics; Animals; Clonidine; Drug Tolerance; Imidazoles; Injections, Spinal; Male; Morphine; Norepinephrine; Pain; Pain Management; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic | 2014 |
Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists.
Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Analgesics, Opioid; Animals; Benzofurans; Cannabinoid Receptor Antagonists; Cannabinoids; Dose-Response Relationship, Drug; Drug Tolerance; Gliosis; Imidazoles; Injections, Spinal; Male; Morphine; Neuroglia; Norepinephrine; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Spine | 2018 |